These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 8094911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Are OKT3 binding sites on T cells modulated or merely converted (blindfolded) by OKT3 during therapy?
    Carreno M, Miller J, Esquenazi V, Milgrom M, Roth D, Fuller L.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):987-8. PubMed ID: 2565060
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat.
    Deaton DH, Posselt AM, Naji A, Barker CF.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):283-4. PubMed ID: 1899305
    [No Abstract] [Full Text] [Related]

  • 13. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 14. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL, Wheelahan J, McKenzie IF, Clunie GJ.
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract] [Full Text] [Related]

  • 15. Ability of a CD4-positive, MRC OX22 "low" T-cell subpopulation to initiate renal allograft rejection in the athymic nude rat.
    Bradley JA, Bolton EM, Briggs JD, Gracie JA.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):326-7. PubMed ID: 2650138
    [No Abstract] [Full Text] [Related]

  • 16. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P, Kern F, Fietze E, Döcke WD, Ewert R, Emmrich F, Volk HD.
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH, Bach JF, Chatenoud L.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract] [Full Text] [Related]

  • 19. Phenotypic and functional analysis of kidney infiltrating T cells escaping monoclonal antibody treatment in primate renal transplantation.
    Nocera A, Cosimi AB, Colvin RB, Gesner ML, Fuller TC.
    Transplant Proc; 1988 Apr; 20(2):205-6. PubMed ID: 3129830
    [No Abstract] [Full Text] [Related]

  • 20. Complications of monoclonal antibody (MAb) therapy: the importance of primate studies.
    Jonker M, Schellekens PT, Harpprecht J, Slingerland W.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):264-5. PubMed ID: 1824980
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.